MARATTO

article · International Journal of Research Publications

BACTERIAL INFECTION AND ANTIMICROBIAL SUSCEPTIBILITSY TEST (AST) PATTERNS AMONG CONFIRMED SARS COV-2 INDIVIDUAL IN SOUTHWESTERN NIGERIA.

Abstract

Antimicrobial medications were given to patients with this illness without antimicrobial susceptibility since recent statistics on SARS-C0V-2 showed that bacterial infection increased mortality rate and lowered clearance rate of the virus. The goal of this study was to detect co-infecting pathogen(s) and analyze their antibiotic resistance profiles in confirmed SARS-CoV-2 cases in Oyo State, Nigeria. 400 symptomatic and asymptomatic infected individuals had their nasopharynx sampled, and structured questionnaires were given out to identify risk factors for SARS-CoV-2 infection. Using API 20E and VITEK 2.0 ID cards, isolates were recognized after being collected using conventional microbiological techniques. Antimicrobial susceptibility testing was done using VITEK 2.0 AST card kits and Kirby Bauer disc diffusion techniques. The Enterobacteriaceae family had a large number of the observed bacteria. The COVID-19 cases treated with azithromycin, which is more resistant to Gram positive bacteria, had a higher resistance rate (66.6%). However, bacterial isolates have significantly higher quinolone susceptibility (89.0%). Some of the microbiological isolates identified in individuals with SARS-CoV-2 infection were multidrug resistant, including Azithromycin. This discovery raises serious health concerns and requires additional investigation.

Research topics

  • Antibiotic Use and Resistance
  • Pneumonia and Respiratory Infections
  • COVID-19 Clinical Research Studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.47119/ijrp1001211320234577

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.